Published in Biochim Biophys Acta on August 31, 1995
Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. Biochem J (1997) 1.61
Cell shrinkage and monovalent cation fluxes: role in apoptosis. Arch Biochem Biophys (2007) 1.56
The role of apoptotic volume decrease and ionic homeostasis in the activation and repression of apoptosis. Pflugers Arch (2004) 1.39
Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity. Proc Natl Acad Sci U S A (1998) 1.11
Close encounters of the monoamine kind: immune cells betray their nervous disposition. Immunology (2005) 1.01
Dopamine-induced apoptosis is inhibited in PC12 cells expressing Bcl-2. Cell Mol Neurobiol (1997) 0.85
Non-traditional cytokines: How catecholamines and adipokines influence macrophages in immunity, metabolism and the central nervous system. Cytokine (2015) 0.82
Evaluation of the neurotoxic activity of typical and atypical neuroleptics: relevance to iatrogenic extrapyramidal symptoms. Cell Mol Neurobiol (2001) 0.78
Reduced Ca2+ entry and suicidal death of erythrocytes in PDK1 hypomorphic mice. Pflugers Arch (2007) 0.76
Potential Roles of Peripheral Dopamine in Tumor Immunity. J Cancer (2017) 0.75
Encapsulation and capsular types in isolates of Staphylococcus aureus from different sources and relationship to phage types. J Clin Microbiol (1985) 4.88
Prevalence of internalisation-associated gene, prtF1, among persisting group-A streptococcus strains isolated from asymptomatic carriers. Lancet (1999) 2.61
Relapsing myelitis. Neurology (1992) 2.12
Quantitative blood cultures in the evaluation of septicemia in children with Broviac catheters. J Pediatr (1984) 1.98
A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group. N Engl J Med (1994) 1.97
Camptocormia (bent spine) in patients with Parkinson's disease--characterization and possible pathogenesis of an unusual phenomenon. Mov Disord (1999) 1.94
Mesenchymal stem cells induced to secrete neurotrophic factors attenuate quinolinic acid toxicity: a potential therapy for Huntington's disease. Exp Neurol (2012) 1.91
Quantitative measurement of pain sensation in patients with Parkinson disease. Neurology (2004) 1.84
Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology (2001) 1.83
Modulation of an NCAM-related adhesion molecule with long-term synaptic plasticity in Aplysia. Science (1992) 1.78
Open controlled therapeutic trial of intravenous immune globulin in relapsing-remitting multiple sclerosis. Arch Neurol (1992) 1.61
Psychosis in advanced Parkinson's disease: treatment with ondansetron, a 5-HT3 receptor antagonist. Neurology (1995) 1.57
Is routine use of the nasogastric tube justified in upper abdominal surgery? Am J Surg (1980) 1.55
Evaluating dosage compensation on the chicken Z chromosome: should effective dosage compensation eliminate sexual bias? Heredity (Edinb) (2009) 1.55
Enhanced fatigue during motor performance in patients with Parkinson's disease. Neurology (1998) 1.53
Inactivation of gram-negative bacteria by photosensitized porphyrins. Photochem Photobiol (1992) 1.50
Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from Atm-deficient mice. Cancer Res (2001) 1.46
Stethoscopes and otoscopes--a potential vector of infection? Fam Pract (1997) 1.41
Antibodies from ALS patients inhibit dopamine release mediated by L-type calcium channels. Neurology (1998) 1.41
Riluzole for levodopa-induced dyskinesias in advanced Parkinson's disease. Lancet (1999) 1.40
The role of IVIg treatment in severe pemphigus vulgaris. J Eur Acad Dermatol Venereol (2006) 1.39
Optimal needle length of automatic injectors. Crit Care Med (1990) 1.38
Sequencing of proteins from two-dimensional gels by using in situ digestion and transfer of peptides to polyvinylidene difluoride membranes: application to proteins associated with sensitization in Aplysia. Proc Natl Acad Sci U S A (1988) 1.36
Precursor control of neurotransmitter synthesis. Pharmacol Rev (1980) 1.34
Reduction in regional cerebral blood flow during normal aging in man. Stroke (1980) 1.34
Tardive dyskinesia associated with metoclopramide. Br Med J (1978) 1.33
Semaphorins as mediators of neuronal apoptosis. J Neurochem (1999) 1.31
Reactive hyperglycaemia in patients with acute stroke. J Neurol Sci (1976) 1.30
Parallel induction of ATM-dependent pro- and antiapoptotic signals in response to ionizing radiation in murine lymphoid tissue. Oncogene (2006) 1.29
Green fluorescent protein photobleaching: a model for protein damage by endogenous and exogenous singlet oxygen. Biol Chem (2000) 1.29
Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization. Brain Res (1980) 1.27
Increased plasma endothelin-1 in acute ischemic stroke. Stroke (1992) 1.26
Molecular biology of Crohn's disease mycobacteria. Baillieres Clin Gastroenterol (1990) 1.22
Parkinson Psychosis Rating Scale: a practical instrument for grading psychosis in Parkinson's disease. Clin Neuropharmacol (1998) 1.20
Acute "upside down" reversal of vision in transient vertebrobasilar ischemia. Neurology (1987) 1.20
Effect of chronic atrial fibrillation on regional cerebral blood flow. Stroke (1980) 1.16
Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial. Pediatr Infect Dis J (2000) 1.16
Neurotransmitters and the fifth cranial nerve: is there a relation to the headache phase of migraine? Lancet (1979) 1.14
Pseudomonas aeruginosa bacteremia in children: analysis of trends in prevalence, antibiotic resistance and prognostic factors. Pediatr Infect Dis J (2000) 1.13
Influence of environmental temperature on the immune response in fish. Curr Top Microbiol Immunol (1973) 1.13
Spondylosis in sand rats: a model of intervertebral disc degeneration and hyperostosis. J Orthop Res (1990) 1.12
The use of porphyrins for eradication of Staphylococcus aureus in burn wound infections. FEMS Immunol Med Microbiol (1997) 1.11
Aromatic L-amino acid decarboxylase in rat corpus striatum: implications for action of L-dopa in parkinsonism. Neurology (1981) 1.11
Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity. Proc Natl Acad Sci U S A (1998) 1.11
Long term neurological outcome of herpes encephalitis. Arch Dis Child (1999) 1.10
Protective effect of insulin-like-growth-factor-1 against dopamine-induced neurotoxicity in human and rodent neuronal cultures: possible implications for Parkinson's disease. Neurosci Lett (2001) 1.10
The "instantaneous" deformation of cartilage: effects of collagen fiber orientation and osmotic stress. Biorheology (1986) 1.09
The prognostic value of the CT scan in conservatively treated patients with intracerebral hematoma. Stroke (1984) 1.09
Skin biopsy for assessment of autonomic denervation in Parkinson's disease. J Neural Transm (Vienna) (2006) 1.09
Relationship between asymptomatic carriage of Streptococcus pyogenes and the ability of the strains to adhere to and be internalised by cultured epithelial cells. J Med Microbiol (2000) 1.08
Paroxysmal dystonia as the initial manifestation of multiple sclerosis. Arch Neurol (1984) 1.08
Structure-activity relationship of porphines for photoinactivation of bacteria. Photochem Photobiol (1995) 1.07
Diagnosis of organophosphate poisoning. West J Med (1986) 1.06
Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents. Neurosci Lett (2005) 1.06
Nonaminergic striatal neurons convert exogenous L-dopa to dopamine in parkinsonism. Ann Neurol (1980) 1.05
Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease. Mov Disord (2001) 1.05
Integral therapeutic potential of bone marrow mesenchymal stem cells. Curr Drug Targets (2005) 1.05
Enhanced oxidative stress and altered antioxidants in brains of Bcl-2-deficient mice. J Neurochem (1998) 1.05
Destruction of erythroleukemia, myelocytic leukemia and Burkitt lymphoma cells by photoactivated protoporphyrin. Int J Cancer (1980) 1.04
Studies of hydration and swelling pressure in normal and osteoarthritic cartilage. Biorheology (1985) 1.04
Direct localisation of beta-adrenoceptor sites in rat cerebellum by a new fluorescent analogue of propranolol. Nature (1976) 1.04
Induction of neuronal apoptosis by Semaphorin3A-derived peptide. Brain Res Mol Brain Res (2000) 1.03
Local application of honey for treatment of neonatal postoperative wound infection. Acta Paediatr (1998) 1.03
Gastric emptying in Parkinson's disease: patients with and without response fluctuations. Neurology (1996) 1.02
Early-morning dystonia. A late side effect of long-term levodopa therapy in Parkinson's disease. Arch Neurol (1979) 1.02
Hemiballismus: detection of focal hemorrhage in subthalamic nucleus by CT scan. Ann Neurol (1978) 1.02
Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease. Cytotherapy (2008) 1.01
Experimental alterations in gastric mucosal cellular population in dogs. JAMA (1966) 1.01
Varicella zoster virus infection associated with erythema multiforme in children. Infection (2001) 1.01
Long-term sensitization training in Aplysia leads to an increase in the expression of BiP, the major protein chaperon of the ER. J Cell Biol (1992) 1.01
5-Aminolevulinic acid stimulation of porphyrin and hemoglobin synthesis by uninduced Friend erythroleukemic cells. Cell Differ (1979) 1.01
A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model. Br J Cancer (1996) 1.01
Placental transfer and decay of varicella-zoster virus antibodies in preterm infants. J Pediatr (2000) 1.01
Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretion. J Clin Invest (1994) 1.00
Handwashing patterns in primary pediatric community clinics. Infection (1998) 1.00
Cultured mouse marrow stromal cell lines. II. Distinct subtypes differing in morphology, collagen types, myelopoietic factors, and leukemic cell growth modulating activities. J Cell Physiol (1985) 0.99
Aesthetic results and patient satisfaction with immediate breast reconstruction using tissue expansion: a follow-up study. Plast Reconstr Surg (1997) 0.99
Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson's disease. Exp Neurol (1996) 0.99
The site of dopamine formation in rat striatum after L-dopa administration. J Pharmacol Exp Ther (1981) 0.99
Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical application. Dermatol Surg (2000) 0.99
Diagnosis of "non-organic" limb paresis by a novel objective motor assessment: the quantitative Hoover's test. J Neurol (1998) 0.98
Long-term sensitization training in Aplysia leads to an increase in calreticulin, a major presynaptic calcium-binding protein. Neuron (1992) 0.98
Isolation, purification, and reconstitution of the Na+ gradient-dependent Ca2+ transporter (Na+-Ca2+ exchanger) from brain synaptic plasma membranes. Proc Natl Acad Sci U S A (1984) 0.98
Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease. Brain Res (2000) 0.98
Distribution of glucose transporters in membrane fractions isolated from human adipose cells. Relation to cell size. J Clin Invest (1986) 0.97
Circling behavior in rats with partial, unilateral nigro-striatal lesions: effect of amphetamine, apomorphine, and DOPA. Pharmacol Biochem Behav (1980) 0.97
Osteoid osteoma of the scapula. A case report and review of the literature. Clin Orthop Relat Res (1991) 0.97
Hemispheric brain damage in unilateral status epilepticus. Ann Neurol (1986) 0.97